Gene: COQ7
Official Full Name: coenzyme Q7, hydroxylaseprovided by HGNC
Gene Summary: The protein encoded by this gene is similar to a mitochondrial di-iron containing hydroxylase in Saccharomyces cerevisiae that is involved with ubiquinone biosynthesis. Mutations in the yeast gene lead to slower development and longer life span. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32097 | COQ7 Knockout cell line (HeLa) | Human | COQ7 | 1:3~1:6 | Negative | Online Inquiry |
KO32098 | COQ7 Knockout cell line (HCT 116) | Human | COQ7 | 1:2~1:4 | Negative | Online Inquiry |
KO32099 | COQ7 Knockout cell line (HEK293) | Human | COQ7 | 1:3~1:6 | Negative | Online Inquiry |
KO32100 | COQ7 Knockout cell line (A549) | Human | COQ7 | 1:3~1:4 | Negative | Online Inquiry |
COQ7 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the functional implications of the COQ7 gene, which plays a crucial role in the biosynthesis of coenzyme Q10 (CoQ10), a vital component for cellular energy metabolism and antioxidant defense. These knockout cell lines are created through advanced CRISPR/Cas9 technology, resulting in a precise deletion of the COQ7 gene, thereby enabling researchers to investigate the effects of its absence on cellular processes, metabolic functions, and disease mechanisms, particularly in contexts such as mitochondrial disorders and aging.
The primary mechanism of these cell lines lies in their ability to facilitate gene function analysis, pathophysiological modeling, and pharmaceutical screening. By eliminating the COQ7 gene, researchers can elucidate the downstream effects on mitochondrial efficiency, reactive oxygen species production, and cellular stress responses. This makes them invaluable in dissecting the multifaceted roles of coenzyme Q10 in health and disease, as well as identifying potential therapeutic targets or compensatory pathways in metabolic syndromes.
From a scientific perspective, COQ7 Gene Knockout Cell Lines present a significant advancement over traditional cell models, which may not adequately mimic the biological nuances of gene knockouts. These specialized lines allow for high-throughput screening and more reliable in vitro experimentation, enabling robust data collection and validation in both research and clinical applications, particularly in drug discovery and toxicity testing.
One of the unique selling points of these cell lines is their consistency and reproducibility, which are paramount for experimental integrity. Additionally, they are readily amenable to a variety of downstream applications, including gene expression analysis, metabolomics, and cellular repair studies. This versatility makes them an appealing choice for academic and industrial laboratories focused on mitochondrial research and metabolic health.
Our commitment to quality and innovation in biological product development ensures that researchers and clinicians have access to cutting-edge tools tailored to their needs. By leveraging our expertise in genetic engineering and cell line development, we strive to empower the scientific community to make discoveries that advance our understanding of human health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.